GSK
GSK·NYSE
--
--(--)
--
--(--)
GSK fundamentals
GSK (GSK) Revenue Breakdown: Q4 2025 Business & Regional Performance
GSK (GSK) reported total revenue of 11.59B USD in Q4 2025, with its core business segment Specialty Medicines contributing 44.15%. Regionally, United States remained the largest market, accounting for 51.55% of total revenue. Explore GSK's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
GSK (GSK) reported total revenue of 11.59B USD in Q4 2025, with its core business segment Specialty Medicines contributing 44.15%. Regionally, United States remained the largest market, accounting for 51.55% of total revenue. Explore GSK's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the market's earnings forecast for GSK next quarter?What is the revenue and EPS growth rate for GSK year over year?What were the key takeaways from GSK’s earnings call?What is GSK's latest dividend and current dividend yield?Did GSK beat or miss consensus estimates last quarter?What is GSK's gross profit margin?What guidance did GSK's management provide for the next earnings period?What does GSK do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
